Takeda Chemical Industries Ltd.: Lessons from a Japanese Pharma Major|Business Strategy|Case Study|Case Studies

Takeda Chemical Industries Ltd.: Lessons from a Japanese Pharma Major

            
 
Case Studies in Business, Management Cases | Case Study

ICMR HOME | Case Studies Collection

Case Details:

Case Code : BSTR074
Case Length : 20 Pages
Period : 2003
Organization : Takeda Chemical Ltd.
Pub Date : 2003
Teaching Note :Not Available
Countries : Japan
Industry : Automobile

To download Takeda Chemical Industries Ltd.: Lessons from a Japanese Pharma Major case study (Case Code: BSTR074) click on the button below, and select the case from the list of available cases:

Business Ethics Case Studies | Case Study in Management, Operations, Strategies, Business Ethics, Case Studies


OR


Buy With PayPal

Amount to be paid:



Prefer to pay in another currency ?
Select Currency for Payment



Exchange Rates: Click Here
Delivery Details: Click Here



Price:

For delivery in electronic format: Rs. 500;
For delivery through courier (within India): Rs. 500 + Shipping & Handling Charges extra

Business Strategy Case Studies
Business Strategy Short Case Studies
View Detailed Pricing Info
How To Order This Case
Business Case Studies
Area Specific Case Studies
Industry Wise Case Studies
Company Wise Case Studies

Custom Search


Please note:

This case study was compiled from published sources, and is intended to be used as a basis for class discussion. It is not intended to illustrate either effective or ineffective handling of a management situation. Nor is it a primary information source.



Chat with us

Strategic Management Formulation, Implementation, & Control, 12e

Please leave your feedback

Leave Your Feedback

ICMR India ICMR India ICMR India ICMR India RSS Feed

<< Previous

Introduction Contd...

Takeda owned/produced four highly successful drugs [Actos (for treating diabetes), Lansoprazole (for treating ulcers), Lupron Depot (for treating prostate cancer) and Cendesartan (for hypertension)]. In addition, the company had as many important new drugs in the pipeline as some of the world's biggest pharmaceutical companies. Keeping in view the growth oriented initiatives taken by the company, industry observers stated that Takeda was all set to emerge as a major global player in the near future. It already was one of the fastest growing Japanese pharmaceutical companies, a fact amply reflected in its strong financial performance over the years. In 2002, Takeda posted consolidated profits of $8.9 billion. It was the only Japanese company that had posted record profits and sales for 10 consecutive years (Refer Exhibit I for a 10-year summary of Takeda's key financial data).

Background Note

Takeda was established in 1781 in Japan as a small wholesale outfit dealing in medicines in Doshomachi, Osaka (a commercial center for medicine trade in Japan) by Chobei Takeda I. The wholesaler sold traditional Japanese and Chinese medicines (bought from bigger wholesalers) to local doctors and medicine retailers. In the decades that followed, Takeda emerged as a dominant player even as many big and small wholesalers and retailers mushroomed in the country. The Takeda family had been in the business of selling traditional medicines for over four generations. This business continued until 1871 when Chobei Takeda IV and a group of other medicine retailers decided to sell Western medicine as well.

Business Strategy | Case Study in Management, Operations, Strategies, Business Strategy, Case Studies

Chobei Takeda IV formed co-operative unions in Yokohama for purchasing foreign medicines and began transactions with foreign trading companies.

The first Western medicines imported at that time included Quinine (used for treating malaria) and Phenol (used for treating cholera). By the mid-1890s, Takeda was importing drugs directly from US, England, Germany, Spain and many other countries. In 1895, the drugs selling business was extended to manufacturing drugs with a manufacturing facility being set up at Osaka. The factory produced drugs like Subgallate, used in treating diarrhea and Quinine Hydrochloride, used in treating malaria. By 1907, Takeda obtained exclusive sales rights from Bayer, a German pharmaceutical company, to sell its products in Japan. By the turn of the 20th century, Takeda shifted its primary focus to Western medicines...

Excerpts >>


Custom Search



 

Case Studies in Business Strategy Volume VI

Case Studies in Business Strategy
e-Book on Business Strategy

Case Study Volumes Collection

 

Case Studies Links:- Case Studies, Short Case Studies, Simplified Case Studies.

Other Case Studies:- Multimedia Case Studies, Cases in Other Languages.

Business Reports Link:- Business Reports.

Books:- Textbooks, Workbooks, Case Study Volumes.